SG/PUT/STRYKER CORP./300/0.1/20.09.24 Stock

Warrant

DE000SV6Q023

Market Closed - Deutsche Boerse AG 15:44:13 2024-05-31 EDT
0.38 EUR +5.56% Intraday chart for SG/PUT/STRYKER CORP./300/0.1/20.09.24
3 months-43.28%
6 months-84.03%
Date Price Change
24-05-31 0.38 +5.56%
24-05-30 0.36 +2.86%
24-05-29 0.35 -5.41%
24-05-28 0.37 +12.12%
24-05-27 0.33 -13.16%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:44 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SV6Q02
ISINDE000SV6Q023
Date issued 2023-05-24
Strike 300 $
Maturity 2024-09-20 (110 Days)
Parity 10 : 1
Emission price 3.46
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.96
Lowest since issue 0.28
Spread 0.01
Spread %2.86%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus